It selectively inhibits the activity of histone deacetylase (HDAC) in tumor cells, to regulate tumor epigenetics, and to induce and enhance the effect of killing tumor cells; moreover, its selectivity improves tumor cell resistance and inhibits tumor recurrence and metastasis. This evidence concerns the gene HDAC9 and neoplasm.